Exploring Patient Perspectives Surrounding Telemedicine Versus In-Person Preoperative Visits
Davenport A, Brunn E, Creswell M, Sholklapper T, Ringel N, Gutman R. Exploring Patient Perspectives Surrounding Telemedicine Versus In-Person Preoperative Visits. Urogynecology 2022, 29: 545-551. PMID: 36701389, DOI: 10.1097/spv.0000000000001310.Peer-Reviewed Original ResearchConceptsTelemedicine visitsPreoperative visitPerson visitsVisit contentPreoperative physical examinationSingle academic institutionRole of telemedicineInvasive gynecologic surgeonsHigh satisfactionSurgical severityPreoperative appointmentOffice visitsGynecologic surgeryPhysical examinationSurgical preparednessUrogynecologic surgeonsPatient's perspectiveSurgical experiencePatient experienceGynecologic surgeonsVisitsSurgical specialtiesSurgeons' perceptionsPhone interviewsSurgeryPostprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Urogynecology 2022, 28: 518-525. PMID: 35543540, DOI: 10.1097/spv.0000000000001199.Peer-Reviewed Original ResearchConceptsUrgency urinary incontinenceOveractive bladderProcedure timeIntradetrusor injectionsAdverse eventsUrinary incontinenceClinical trialsSubjective efficacyAverage pain scoreGlobal response assessmentRefractory overactive bladderIdiopathic overactive bladderVisual analog scalePain scoresOnabotulinumtoxinA treatmentPain AssociatedPain levelsWeeks postprocedurePostprocedure complicationsAnalog scaleProcedure durationResponse assessmentPatient experiencePatientsInjection paradigm